VIVUS 3.75/23 (Qsymia phentermine hydrochloride 3.75 mg (base) / topiramate extended-release 23 mg)
Generic Name: phentermine/topiramate
This pill with imprint "VIVUS 3.75/23" is Purple, Capsule-shape and has been identified as Qsymia phentermine hydrochloride 3.75 mg (base) / topiramate extended-release 23 mg. It is supplied by Vivus, Inc..
Qsymia is used in the treatment of weight loss; obesity and belongs to the drug class anorexiants. Not for use in pregnancy. Qsymia phentermine hydrochloride 3.75 mg (base) / topiramate extended-release 23 mg is classified as a Schedule 4 controlled substance under the Controlled Substance Act (CSA).
Qsymia
- Generic Name:
- phentermine/topiramate
- Imprint:
- VIVUS 3.75/23
- Strength:
- phentermine hydrochloride 3.75 mg (base) / topiramate extended-release 23 mg
- Color:
- Purple
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Anorexiants
- Pregnancy Category:
- X - Not for use in pregnancy
- CSA Schedule:
- 4 - Some potential for abuse
- Labeler / Supplier:
- Vivus, Inc.
- Inactive Ingredients:
- sucrose
corn starch
microcrystalline cellulose
ethylcelluloses
povidone k30
gelatin
magnesium silicate
titanium dioxide
FD&C Blue No. 1
FD&C Red No. 3
Note: Inactive ingredients may vary.
Submitted by: pillstress
More about Qsymia (phentermine / topiramate)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 448 Reviews – Add your own review/rating
- Drug class: anorexiants
Consumer resources
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
